70377-091Level 3
Everolimus (Everolimus)
**Product type:** Human Prescription Drug
**Active ingredient:** EVEROLIMUS
**Strength:** 3 mg/1
**Dosage form:** Tablet, For Suspension
**Route:** Oral
**Labeler:** Biocon Pharma Inc.
**Marketing category:** ANDA (ANDA217216)
**Pharmacologic class:** Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/70377-091Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.